Non-Hodgkin's Lymphoma Perspective

 
 
  • T-Cell Lymphomas: Moving Forward, Improving Outcomes Dr. Julie Vose discusses some of the challenges in diagnosis and management of T-cell lymphomas and looks at how new, targeted therapies offer hope for better outcomes.
  • BRIGHT Shines Light on R-Bendamustine in Lymphoma   At 50 years of age, bendamustine holds its own against standard regimens in lymphoma.
  • New Lymphoma Drugs Send Chemo Packing Have we really reached the end of the chemotherapy era in the treatment of lymphoma?
  • 'R-Squared' Rates 98% Response in Lymphoma Patients Drs. Bruce Cheson and Nathan Fowler discuss the results of the R-squared study and speculate whether in 5 years lymphoma management will no longer have a place for chemotherapy.
  • ASH 2012: More Fuel for the Fire   Dr. Bruce Cheson highlights studies that should prove controversial and practice-changing, as well as new drugs that expand treatment options.
  • A Challenger to Interim PET in Lymphoma   Dr. Bruce Cheson reports on recent data suggesting that measurement of metabolic tumor volume and total lesion glycolysis may be a better predictor of outcome in lymphoma than interim PET scanning.
  • Follicular Lymphoma: Watch and Wait for Better Therapies?   Dr. Bruce Cheson comments on the significance of 2 studies that show no survival advantage between watchful waiting and treatment in patients with early follicular lymphoma.
  • Bortezomib Combo Keeps on Giving in Myeloma   Dr. Martin Dreyling highlights presentations in blood cancers at ESMO 2012, including important findings on bortezomib, combinations of prognostic markers, and ways to deliver personalized treatment.
  • Critical Limb Ischemia From Burkitt's Lymphoma A 28-year-old man with HIV is treated for critical limb ischemia from Burkitt's lymphoma.
  • When an Incurable Cancer Meets a New Genetic Target   Dr. Maurie Markman looks at the broader implications of finding a single genetic mutation in 90% of patients with Waldenström macroglobulinemia.
  • Why the Holdup on New Combo Therapies in Lymphoma?   Clinical trials to test combinations of therapies in Hodgkin lymphoma have hit bureaucratic bottlenecks, much to the frustration of Dr. Bruce Cheson.
  • Best Regimens for Lymphoma Patients With Bad Hearts   Dr. Bruce Cheson reports the best evidence on treatment options available for lymphoma patients who have cardiac impairment.
  • Lymphoma: Radiation Therapy for DLCL?   Dr. Martin Dreyling reviews the highlights of the lymphoma studies presented at the 2012 annual meeting of the European Hematology Association.
  • Targeted Therapy in Pediatric Cancers   Does crizotinib offer a potential step forward in treatment of childhood cancers?
  • Lymphoma: More a Question of Toxicity Than Efficacy   Drs. Bruce Cheson and Gilles Salles discuss provocative studies in Hodgkin lymphoma and non-Hodgkin lymphoma presented at ASCO® 2012.
  • ASCO® Wrap-up: Tools to Beat a Smart Tumor   Four leading oncologists discuss the top studies from ASCO® 2012 and how the tsunami of molecular information is reshaping cancer care and practice.
  • Blood Cancers: Lymphoma, Myeloma Preview   Dr. Bruce Cheson previews studies to be presented at ASCO® 2012 that will change or confirm therapies in follicular lymphoma, Hodgkin lymphoma, myeloma, and more.
  • Another 'CLL Case' Cured   Dr. Bruce Cheson discusses a patient referral that serves as a reminder that healthy persons can harbor markers of disease when no disease is present.
  • Plenary Session: 4 Critical Advances in Oncology   Dr. Kathy Miller previews the ASCO plenary session studies in breast cancer, prostate cancer, lymphoma, and oligodendroglioma, all 4 of which signal significant advances in science and treatment.
  • When Patients Think They Know Best   Dr. Bruce Cheson reports on 2 patients with Hodgkin lymphoma: one who wants more therapy, the other less. When patients think they know best, how can docs convince them of the right therapy?
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.